SCHEMBL6427708

SCHEMBL6427708

O=C1C(Cl)=C(c2ccc(Cl)cc2)C(=O)N1Cc1cccc(Oc2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 3/20 0.50
NR1H3 Q13133 3/20 0.50
ALDH1A1 P00352 4/20 0.46
FAAH O00519 2/20 0.45
LMNA P02545 2/20 0.45
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
CCR8 P51685 1/20 0.44
KCNH2 Q12809 1/20 0.44
KDM4E B2RXH2 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
PGGT1B P53609 1/20 0.41
DAGLA Q9Y4D2 1/20 0.41
CXCR2 P25025 1/20 0.41
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6427394 0.90 NR1H2 (0.51) NR1H2NR1H3FAAHPPARGPPARA
SCHEMBL6426743 0.87 CMA1 (0.57) NR1H2NR1H3ALDH1A1LMNAPPARG
SCHEMBL6427927 0.83 MAPT (0.52) NR1H2NR1H3ALDH1A1LMNAPPARG
SCHEMBL6427000 0.81 NR1H2 (0.60) NR1H2NR1H3ALDH1A1FAAHLMNA
SCHEMBL6428843 0.79 NR1H2 (0.52) NR1H2NR1H3ALDH1A1FAAHLMNA
SCHEMBL15923547 0.76 KMT2A (0.60) ALDH1A1FAAHLMNAKDM4ETDP1
SCHEMBL6428883 0.76 NR1H2 (0.48) NR1H2NR1H3ALDH1A1LMNAKDM4E
SCHEMBL6427259 0.76 ADRA1D (0.49) NR1H2NR1H3ALDH1A1KDM4ETDP1
SCHEMBL6426484 0.76 APAF1 (0.52) NR1H2NR1H3ALDH1A1TDP1MEN1
SCHEMBL6429547 0.75 CMA1 (0.54) NR1H2NR1H3ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005024755-A2 MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS OR DIABETES DECIPHERA PHARMACEUTICALS, LLC. (US) 2005-03-17 WO disclosed